A breast cancer treatment study published in the New England Journal of Medicine this week has the national media hopping–and me wondering why.
The study throws into question the use of Taxol (paclitaxel) as an effective chemotherapy drug for women with HER2-negative, ER-positive (estrogen receptive positive) breast cancer.
Researchers went back and retrieved frozen tissue samples from 1,500 women with breast cancer who were part of a 3,121-participant study back in the ’90s. The original...
Q. I've just found out I have to have chemotherapy. The doctor said it's AC and Taxol [or Taxotere]. What does that mean, exactly? A.... Read more »
After enduring four grueling rounds of Taxol during my chemotherapy treatments, imagine my disappointment upon learning that it may have... Read more »
Q. Unfortunately, I’ve just found out I need to have chemo. With no node involvement I thought I’d avoid it, but my Oncotype score is... Read more »
My daughter Sarah's high school graduation was in June. My sister gave her a week's trip to Ireland. To say the least, Sarah is the... Read more »
I just returned from a week-long family reunion on the Gulf coast. No oil while we were there although it did start washing up the day... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
